Eiger BioPharmaceuticals, Inc.
EIGRDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001305253
Eiger BioPharmaceuticals, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 43 institutions reported holding it in 13F filings for Q4 2023, worth $4.16M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Eiger BioPharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 90 | 92 | +2 |
| Shares | 23.0M | 22.6M | −450.5K (−2.0%) |
| Value | $196.3M | $151.0M | −$45.3M (−23.1%) |
New holders (9)
Institutions that held Eiger BioPharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 67,563 | $451.0K | 0.00% |
| Citadel Advisors LLC | 60,577 | $405.0K | 0.00% |
| Apis Capital Advisors, LLC | 40,000 | $267.0K | 0.25% |
| DuPont Capital Management Corp | 32,022 | $214.0K | 0.01% |
| SG Americas Securities, LLC | 22,649 | $151.0K | 0.00% |
| HRT Financial LP | 19,362 | $129.0K | 0.00% |
| Millennium Management LLC | 17,321 | $116.0K | 0.00% |
| ExodusPoint Capital Management, LP | 12,903 | $86.0K | 0.00% |
| Wolverine Trading, LLC | 11,253 | $76.0K | 0.00% |
Sold out (7)
Institutions that held Eiger BioPharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Cormorant Asset Management, LP | 284,988 | $2.43M |
| Laurion Capital Management LP | 72,925 | $621.0K |
| Jacobs Levy Equity Management, Inc | 60,008 | $511.0K |
| Manufacturers Life Insurance Company, The | 21,902 | $187.0K |
| Acadian Asset Management LLC | 13,345 | $114.0K |
| Quantbot Technologies LP | 2,312 | $19.0K |
| FMR LLC | 175 | $1.00K |